Generalized Pustularpsoriasis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Impetigo Herpetiformis: a Case Report
Perinatal Journal • Vol: 13, Issue: 4/December 2005 227 Impetigo Herpetiformis: A Case Report ‹ncim Bezircio¤lu1, Merve Biçer1, Levent Karc›1, Füsun Özder2, Ali Balo¤lu1 1First Clinic of Gynecology and Obstetrics, 2Clinics of Dermatology, Atatürk Training and Research Hospital, ‹zmir Abstract Objective: Impetigo herpetiformis is a rare and potentially life-threatening pustular dermatosis affecting mainly pregnant women. We report here a case of impetigo herpetiformis which occured in twenty-ninth week of pregnancy. Case: A 32 year old gravida 2, para1 pregnant woman who was referred to our institution because of congestive heart failure, gestational diabetes mellitus and oligohidroamnios in 27th gestational age was hospitalized. Eruptive pustular lesions which appeared in 29th week of the gestation has spread her entire body. Her pustular cultures were negative. A punch skin biopsy from a pustule on the trunk made the diagnosis of impetigo herpetiformis. The patient who developed spontaneous uterine contractions was treated with betamethazone and tocolysis. The patient who did not respond to this treatment was taken to delivery at 30 weeks of gestation.The newborn showed no skin lesions after birth. The skin lesions of the mother improved in the second postpartum week. Conclusion: The rates of maternal mortality and fetal mortality and morbidity due to placental insufficiency are increased in impetigo herpetiformis. To reduce the mortality and morbidity rates the antenatal management of impetigo herpetiformis should be organized with a multidisciplinary approach. Keywords: Impetigo herpetiformis, generalized pustular psoriasis. Impetigo herpetiformis: Bir olgu sunumu Amaç: ‹mpetigo herpetiformis gebelerde görülen yaflam› riske edebilen nadir bir püstüler dermatozdur. Bu çal›flmada 29.gebe- lik haftas›nda ortaya ç›kan impetigo herpetiformis olgusu sunulmufltur. -
Jemds.Com Original Research Article
Jemds.com Original Research Article A CLINICO-AETIOLOGICAL STUDY OF CASES OF ERYTHRODERMA ATTENDING TERTIARY CARE HOSPITAL IN NORTH-EAST INDIA Jahnabi Boruah1, Bhaskar Gupta2 1Postgraduate Resident, Department of Dermatology, Silchar Medical College, Silchar, Assam, India. 2Professor and HOD, Department of Dermatology, Silchar Medical College, Silchar, Assam, India. ABSTRACT BACKGROUND Erythroderma is the term used for any inflammatory skin disease that affects more than 90% of the body surface area.1 It has many underlying causes and finding the aetiology helps in proper management of cases. Aim- To study and analyse the different causes of erythroderma. MATERIALS AND METHODS The study was performed in Silchar Medical College and Hospital, Silchar, Assam. A total of 30 cases of erythroderma were studied with respect to epidemiological, clinical and histological finding. RESULTS Among 30 cases, 21 were male and 9 were female patients with male-to-female ratio of 2.3: 1 and mean age of incidence was found to be 53.26% yrs. In our study, the most common aetiology was found to be psoriasis (n= 14, 46.6%), atopic dermatitis (n= 5, 16.6%), drug-induced erythroderma (n= 3, 10%), allergic contact dermatitis (n= 3, 10%), dermatophytosis and pemphigus foliaceus (one case each) and 3 idiopathic cases (10%). CONCLUSION Although clinical presentation of most of the patients was similar, a detailed history, physical examination and histopathological examination helped us to reach most of the diagnosis. KEY WORDS Erythroderma, Clinico-Aetiological Study, North-East India. HOW TO CITE THIS ARTICLE: Boruah J, Gupta B. A clinico-aetiological study of cases of erythroderma attending tertiary care hospital in North-East India. -
A Study of Correlation Between Clinical and Histopathological
ORIGINAL ARTICLE A Study of Correlation Between Clinical and Histopathological Findings of Erythroderma in North Bengal Population Sabyasachi Banerjee, Swarup Ghosh1, Rajesh Kumar Mandal2 Abstract From the Department of Background: Erythroderma is a reaction pattern characterized by erythema and Dermatology, STD and Leprosy desquamation of 90% or more body surface area along with some metabolic alterations. Malda Medical College, 1 Materials and Methods: Here we studied 32 patients of erythroderma at of North Bengal Medical Department of Pathology, Asansol SD Hospital, Burdwan, 2Department College for a period of 1 year to find the etiology, clinical features and histological changes. of Dermatology, STD, and Leprosy, Detailed history was taken from all the patients followed by relevant biochemical investigations North Bengal Medical College, and histological examination. To correlate the clinical and histopathological findings chi square Darjeeling, West Bengal, India test was used. Results: Male preponderance was present and most of them were in the 4th or 5th decade. Etiologically the patients were divided into secondary erythroderma developing over pre-existing dermatoses, and idiopathic erythroderma. Secondary erythroderma (n = 24) Address for correspondence: cases outnumbered the idiopathic cases (n = 8). Among the pre-existing dermatoses, psoriasis Dr. Rajesh Kumar Mandal, was found to be the most common etiologic agent. Apart from erythema the other common Department of Dermatology, STD, presenting features were scaling and itching. Histopathological categorization was possible in and Leprosy, North Bengal Medical 59.3% cases, rest of the cases showed non-specific dermatitis. The most common histopathologic College, Darjeeling, West Bengal, diagnosis was psoriasis (21.8% of cases). Conclusions: Our study of clinicopathological India. -
A 29-Year-Old Man Presented to the Dermatology Clinic with a Pruritic, Erythematous, and Scaly Rash That Had First Appeared 2 Years Earlier
A 29-year-old man presented to the dermatology clinic with a pruritic, erythematous, and scaly rash that had first appeared 2 years earlier. He had sought no medical treatment until this presentation. His medical history included eczema during childhood and seasonal allergies. Physical examination showed erythematous, violaceous plaques that involved more than 90% of the patient’s body-surface area, with some areas that were spared and reflect the baseline appearance of the patient’s skin. What is the diagnosis? Seborrheic dermatitis The answer is erythrodermic psoriasis. The differential Pityriasis rubra pilaris diagnosis for generalized erythema and plaque formation includes erythrodermic psoriasis, seborrheic Erytherma multiforme dermatitis, and pityriasis rubra pilaris. A punch biopsy specimen obtained from two areas on the back Erythrodermic psoriasis confirmed the diagnosis of erythrodermic psoriasis. An erythrodermic papulosquamous eruption can be Toxic Epidermal Necrolysis associated with an underlying systemic disease. In this case, testing for human immunodeficiency virus (HIV) infection was positive. Psoriatic erythroderma (also known as erythrodermic psoriasis) represents a generalized form of psoriasis that affects all body sites, including the face, hands, feet, nails, trunk, and extremities. First-line treatments for psoriatic erythroderma include immunosuppressive medications such as methotrexate, acitretin, or ciclosporin. Erythroderma is a generalised redness of the skin. It is a very severe skin condition that can be -
Diagnosis and Management of Cutaneous Psoriasis: a Review
FEBRUARY 2019 CLINICAL MANAGEMENT extra Diagnosis and Management of Cutaneous Psoriasis: A Review CME 1 AMA PRA ANCC Category 1 CreditTM 1.5 Contact Hours 1.5 Contact Hours Alisa Brandon, MSc & Medical Student & University of Toronto & Toronto, Ontario, Canada Asfandyar Mufti, MD & Dermatology Resident & University of Toronto & Toronto, Ontario, Canada R. Gary Sibbald, DSc (Hons), MD, MEd, BSc, FRCPC (Med Derm), ABIM, FAAD, MAPWCA & Professor & Medicine and Public Health & University of Toronto & Toronto, Ontario, Canada & Director & International Interprofessional Wound Care Course and Masters of Science in Community Health (Prevention and Wound Care) & Dalla Lana Faculty of Public Health & University of Toronto & Past President & World Union of Wound Healing Societies & Editor-in-Chief & Advances in Skin and Wound Care & Philadelphia, Pennsylvania The author, faculty, staff, and planners, including spouses/partners (if any), in any position to control the content of this CME activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity. To earn CME credit, you must read the CME article and complete the quiz online, answering at least 13 of the 18 questions correctly. This continuing educational activity will expire for physicians on January 31, 2021, and for nurses on December 4, 2020. All tests are now online only; take the test at http://cme.lww.com for physicians and www.nursingcenter.com for nurses. Complete CE/CME information is on the last page of this article. GENERAL PURPOSE: To provide information about the diagnosis and management of cutaneous psoriasis. TARGET AUDIENCE: This continuing education activity is intended for physicians, physician assistants, nurse practitioners, and nurses with an interest in skin and wound care. -
Clinical Management and Update on Autoinflammatory
1 1 American Journal of Clinical Dermatology 2 Review Article 3 4 Generalized pustular psoriasis: Clinical management and update on autoinflammatory 5 aspects 6 7 Takuya Takeichi, MD, PhD and Masashi Akiyama, MD, PhD 8 9 Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan 10 11 Corresponding Author: 12 Takuya Takeichi, MD, PhD 13 Department of Dermatology, Nagoya University Graduate School of Medicine 14 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan 15 Tel: +81-52-744-2314, Fax: +81-52-744-2318 16 E-mail: [email protected] 17 Masashi Akiyama, MD, PhD 18 E-mail: [email protected] 19 20 Running heading: Review of GPP as autoinflammatory disease 21 22 Compliance with Ethical Standards: 23 Author: Takuya Takeichi 24 Funding sources: JSID’s Fellowship Shiseido Research Grant 2019 to TT. 25 Conflicts of interest: None declared 1 2 26 27 Author: Masashi Akiyama 28 Funding sources: JSID’s Fellowship Shiseido Research Grant 2019 to TT. 29 Conflicts of interest: None declared 30 31 32 Word, table and figure counts: 3,371/6,000 words, 60 references, 4 tables, 1 figure 33 2 3 34 Abstract 35 Generalized pustular psoriasis (GPP) is a chronic, systemic inflammatory disease accompanied 36 by high fever and general malaise. Diffuse erythema and swelling of the extremities occur with 37 multiple sterile pustules all over the body in GPP patients. GPP often relapses over the lifetime 38 and can be life-threatening. Recent discoveries of the underlying molecular genetic basis of 39 many cases of this disorder have provided major advances to clinicians and researchers towards 40 an understanding of the pathomechanism of GPP. -
(12) Patent Application Publication (10) Pub. No.: US 2003/0185915A1 Carlo Et Al
US 2003.0185915A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0185915A1 Carlo et al. (43) Pub. Date: Oct. 2, 2003 (54) SYNERGETIC COMPOSITION FOR THE Publication Classification TREATMENT OF PSORASIS AND OTHER SKN DISORDERS AND METHOD (51) Int. CI.7. ... A61K 35/78 THEREFOR (52) U.S. Cl. .............................................................. 424/744 (76) Inventors: Jaime Carlo, Tampa, FL (US); Nestor Chinea, Bayamon, PR (US); Carmelo (57) ABSTRACT Rivera, Yauco, PR (US); Juan Franco, San Juan, PR (US) Synergetic compounded medication formula for the treat ment of psoriasis, Seborrhea, dermatitis, dandruff, eczema, Correspondence Address: acne, and other skin disorders. The present invention is to EUGENIO J. TORRES provide regenerative treatment of Skin disorders recurrent in FERRAMAR BUILDING all areas of the body. The invention of this disclosure uses a SUTE 1 well-known corticosteroid as an active ingredient, namely 1060 ASHFORD AVENUE Triamcinolone acetonide, which when used in combination SANJUAN, PR 00907 (US) with a Special formula is effective, easy to use, and leSS expensive than Similar products available with a prescription (21) Appl. No.: 10/109,453 in the market. A method for administering Said composition to inhibit proliferation of psoriatic cell populations in the (22) Filed: Mar. 28, 2002 epidermis is disclosed US 2003/0185915 A1 Oct. 2, 2003 SYNERGETIC COMPOSITION FOR THE The plaques resemble multi-layered Scales of skin. In the TREATMENT OF PSORASIS AND OTHER SKIN area where Scales have been shed, tiny bleeding points called DSORDERS AND METHOD THEREFOR “AuSpitz Sign” appear. 0010. The major pathophysiological events involved in STATEMENT REGARDING FEDERALLY the disease process are accelerated epidermal proliferation SPONSORED RESEARCH AND and metabolic activity, proliferation of capillaries in the DEVELOPMENT dermal region, and invasion of the dermis and epidermis by inflammatory cells. -
Guideline on Clinical Investigation of Medicinal Products Indicated for the Treatment of Psoriasis
European Medicines Agency Evaluation of Medicines for Human Use London, 18 November 2004 CHMP/EWP/2454/02 corr COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS INDICATED FOR THE TREATMENT OF PSORIASIS DISCUSSION IN THE EFFICACY WORKING PARTY October 2002 – October 2003 TRANSMISSION TO CHMP November 2003 RELEASE FOR CONSULTATION November 2003 DEADLINE FOR COMMENTS May 2004 DISCUSSION IN THE EFFICACY WORKING PARTY July – September 2004 TRANSMISSION TO CHMP November 2004 ADOPTION BY CHMP November 2004 DATE FOR COMING INTO OPERATION June 2005 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 74 18 86 13 E-mail: [email protected] http://www.emea.eu.int EMEA 2004 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged GUIDELINE ON CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS INDICATED FOR THE TREATMENT OF PSORIASIS This Guideline is intended to provide guidance for the evaluation of new medicinal products indicated for the treatment of psoriasis. It is intended to give guidance to applicants in planning the overall clinical development studies of new compounds to demonstrate clinical efficacy and safety. It is for guidance only; any deviation from guidelines should be explained and discussed in the Clinical overview. This Guideline should be read in conjunction with Directive 2001/83/EC, and all other pertinent elements outlined in current and future EU and ICH guidelines -
Papulosquamous Disorders (Psoriasis, Lichen Planus
PAPULOSQUAMOUS DISORDERS (PSORIASIS, LICHEN PLANUS & PITYRIASIS ROSEA) Objective of the lecture: • To know the definition of papulosquamous pattern. • To know the group of diseases known as papulosquamous diseases. • Psoriasis pathogenesis, clinical presentation, and management. • Lichen planus pathogenesis, clinical presentation, and management. • Pityriasis rosea pathogenesis, clinical presentation, and management. Done by team leader: Ghada Alhadlaq members: Rawan Alwadee & Deena AlNouwaiser. Revised by: Shrooq Alsomali Before you start.. CHECK THE EDITING FILE Sources: doctor’s slides and notes + Group B teamwork [ Color index: Important|doctor notes|Extra] Papulosquamous diseases: • The term squamous refers to scaling that represents thick Stratum Corneum and thus implies an abnormal keratinization process. - Keratinization is the differentiation of basal keratinocytes. - The basal keratinocytes as they move upward, they accumulate keratin inside them & their organelles totally die. • Papulosquamous diseases are typically characterized by scaly papules (papule = elevated lesion). • It could be papule or plaque, but the papulosquamous is the reaction pattern of the disease which means a reaction (inflammation) inside the skin (within the epidermis & dermis) to a specific thing that presents itself on the surface of the skin with a certain morphology. • Other disease patterns include psoriasiform, lichenoid, bullous, pustular as well as papulosquamous pattern & each has many differential diagnoses. :)الصدفية( Psoriasis • Chronic non-contagious polygenic multisystem inflammatory disease. • Psoriasis can be triggered by infections, trauma, stress and medications. • The characteristic lesion (classical psoriatic lesion) is a sharply demarcated erythematous scaly plaque that may be localized or generalized. • The natural history follows a chronic course with intermittent remissions. • Has two peaks in age of onset (bi-model age presentation): one at 20-30 years and a second at 40-50. -
Treatment of Generalized Pustular Psoriasis of Pregnancy with Infliximab
CASE REPORT Treatment of Generalized Pustular Psoriasis of Pregnancy With Infliximab Burcu Beksac, MD, PhD; Esra Adisen, MD; Mehmet Ali Gurer, MD systemic corticosteroids and cyclosporine. The National PRACTICE POINTS Psoriasis Foundationcopy Medical Board also has included • Generalized pustular psoriasis of pregnancy (GPPP) infliximab among the first-line treatment options for is a rare and severe condition that may lead to com- GPPP.2 Herein, we report a case of GPPP treated with plications in both the mother and the fetus. Effective infliximab at 30 weeks’ gestation and during the postpar- treatment with low impact on the fetus is essential. tum period. • Infliximab, among other biologic agents, may be con- sidered for the rapid clearing of skin lesions in GPPP. Casenot Report A 22-year-old woman was admitted to our inpatient clinic at 20 weeks’ gestation in her second pregnancy for evalua- tion of cutaneous eruptions covering the entire body. The Generalized pustular psoriasis of pregnancy (GPPP) is a rare and lesions first appeared 3 to 4 days prior to her admission severe condition that may impair the health of the mother andDo fetus. and dramatically progressed. She had a history of psoria- Effective treatment is essential, as treatment options for GPPP are sis vulgaris diagnosed during her first pregnancy 2 years limited due to concerns about unfavorable pregnancy outcomes. prior that was treated with topical steroids throughout We report the case of a 22-year-old woman with GPPP that was the pregnancy and methotrexate during lactation for a unresponsive to systemic corticosteroids. We effectively treated the total of 11 months. -
Topographic Differential Diagnosis of Chronic Plaque Psoriasis
Journal of Clinical Medicine Review Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks Paolo Gisondi * , Francesco Bellinato and Giampiero Girolomoni Section of Dermatology and Venereology, Department of Medicine, University of Verona, 37129 Verona, Italy; [email protected] (F.B.); [email protected] (G.G.) * Correspondence: [email protected] Received: 29 September 2020; Accepted: 5 November 2020; Published: 8 November 2020 Abstract: Background: Psoriasis is an inflammatory skin disease presenting with erythematous and desquamative plaques with sharply demarcated margins, usually localized on extensor surface areas. Objective: To describe the common differential diagnosis of plaque psoriasis classified according to its topography in the scalp, trunk, extremities, folds (i.e., inverse), genital, palmoplantar, nail, and erythrodermic psoriasis. Methods: A narrative review based on an electronic database was performed including reviews and original articles published until 1 September 2020, assessing the clinical presentations and differential diagnosis for psoriasis. Results: Several differential diagnoses could be considered with other inflammatory, infectious, and/or neoplastic disorders. Topographical differential diagnosis may include seborrheic dermatitis, tinea capitis, lichen planopilaris in the scalp; lupus erythematosus, dermatomyositis, cutaneous T-cell lymphomas, atopic dermatitis, syphilis, tinea corporis, pityriasis rubra pilaris in the trunk and arms; infectious intertrigo in the inguinal and intergluteal folds and eczema and palmoplantar keratoderma in the palms and soles. Conclusions: Diagnosis of psoriasis is usually straightforward but may at times be difficult and challenging. Skin cultures for dermatophytes and/or skin biopsy for histological examination could be required for diagnostic confirmation of plaque psoriasis. Keywords: psoriasis; plaque psoriasis; differential diagnosis; diagnosis; papulosquamous lesions 1. -
Prevalence of Oral Lesions in Patients with Psoriasis
Med Oral Patol Oral Cir Bucal. 2008 Nov 1;13(11):E703-8. Oral lesions in psoriasis Med Oral Patol Oral Cir Bucal. 2008 Nov 1;13(11):E703-8. Oral lesions in psoriasis Publication Types: Research Prevalence of oral lesions in patients with psoriasis Francisco Hernández Pérez 1, Alejandra Jaimes Aveldañez 1, Ma. de Lourdes Urquizo Ruvalcaba 1, Moises Díaz Barcelot 1, Maria Esther Irigoyen Camacho 2, Ma. Elisa Vega Memije 3, Adalberto Mosqueda Taylor 2 (1) DDS, Oral Pathology and Oral Medicine Specialization, Health Care Department, Universidad Autónoma Metropolitana, Xochimilco (2) Professor, Health Care Department, Universidad Autónoma Metropolitana-Xochimilco (3) MD, Department of Dermatology, Hospital General “Dr. Manuel Gea González”, México, D.F. Correspondence: Dr. Francisco Hernández Pérez Calle Sabinos 4121 Col. Del Gas Azcapotzalco, D.F. 02950 E-mail: [email protected] Received: 19/02/2008 Accepted: 08/06/2008 Hernández-Pérez F, Jaimes-Aveldañez A, Urquizo-Ruvalcaba ML, Díaz-Barcelot M, Irigoyen-Camacho ME, Vega-Memije ME, Mosqueda- Indexed in: Taylor A. Prevalence of oral lesions in patients with psoriasis. Med Oral - Science Citation Index Expanded Patol Oral Cir Bucal. 2008 Nov 1;13(11):E703-8. - Journal Citation Reports © Medicina Oral S. L. C.I.F. B 96689336 - ISSN 1698-6946 - Index Medicus, MEDLINE, PubMed http://www.medicinaoral.com/medoralfree01/v13i11/medoralv13i11p703.pdf - Excerpta Medica, Embase, SCOPUS, - Indice Médico Español Abstract Aim: To determine the prevalence of oral lesions (OL) in patients with psoriasis, and compare these findings with the ones found in patients without this condition. Materials and methods: In the present observational and comparative study, we evaluated 207 patients, with and without psoriasis, attending the dermatological consulting service of a concentration hospital in Mexico City.